发明名称 (OXIME)CARBAMOYL FATTY ACID AMIDE HYDROLASE INHIBITORS
摘要 The present invention relates to novel oxime carbamoyl derivatives and pharmaceutical compositions comprising said derivatives which inhibit fatty acid amide hydrolase. These pharmaceutical compositions are useful for the treatment of conditions which can be effected by inhibiting fatty acid amide hydrolase including, but not limited to, neuropathic pain, emesis, anxiety, altering feeding behaviors, movement disorders, glaucoma, brain injury, and cardiovascular disease.
申请公布号 WO03065989(A2) 申请公布日期 2003.08.14
申请号 WO2003US03222 申请日期 2003.02.04
申请人 BRISTOL-MYERS SQUIBB COMPANY;SIT, SING-YUEN;XIE, KAI;DENG, HONGFENG 发明人 SIT, SING-YUEN;XIE, KAI;DENG, HONGFENG
分类号 C07D295/08;A61K31/27;A61K31/343;A61K31/404;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/443;A61K31/4439;A61K31/444;A61K31/47;A61K31/472;A61K31/5375;A61P1/08;A61P1/14;A61P3/04;A61P9/00;A61P25/02;A61P25/04;A61P25/14;A61P25/22;A61P25/28;A61P27/06;A61P29/02;A61P43/00;C07C271/26;C07C271/28;C07C271/48;C07C271/58;C07C271/60;C07D209/08;C07D209/40;C07D213/53;C07D213/64;C07D213/643;C07D213/65;C07D213/68;C07D215/20;C07D215/22;C07D217/02;C07D295/092;C07D307/91;C07D401/12;C07D405/12 主分类号 C07D295/08
代理机构 代理人
主权项
地址